X0206 3 2019-01-31 0 0001586105 Egalet Corp EGLT 0001702352 Capital Royalty L.P. 1000 MAIN ST., SUITE 2500 HOUSTON TX 77002 0 0 1 0 0001767508 CRG Partners III - Parallel Fund B (Cayman) L.P. 1000 MAIN ST., SUITE 2500 HOUSTON 77002 0 0 1 0 0001651357 CRG Partners III - Parallel Fund (A) L.P. 1000 MAIN ST., SUITE 2500 HOUSTON 77002 0 0 1 0 0001566717 Iroko Pharmaceuticals Inc. 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 0 0 1 0 0001767554 Iroko Properties Inc. 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 0 0 1 0 0001767509 CRG Partners III (Cayman) Lev AIV I L.P. 1000 MAIN ST., SUITE 2500 HOUSTON TX 77002 0 0 1 0 0001767510 CRG Partners III (Cayman) Unlev AIV I L.P. 1000 MAIN ST., SUITE 2500 HOUSTON TX 77002 0 0 1 0 0001637591 CRG Partners III L.P. 1000 MAIN ST., SUITE 2500 HOUSTON TX 77002 0 0 1 0 Common Stock 4586874 I By Iroko Properties Inc. Warrants 0.001 Common Stock 2436459 I By Iroko Properties Inc. The shares of Common Stock (the "Shares") and the Warrants are owned directly by Iroko Properties Inc., which is a wholly owned subsidiary of Iroko Pharmaceuticals Inc. CRG Partners III - Parallel Fund "B" (Cayman) L.P., CRG Partners III (Cayman) Lev AIV I L.P., CRG Partners III (Cayman) Unlev AIV I L.P., CRG Partners III L.P. and CRG Partners III - Parallel Fund "A" L.P. (collectively, the "Funds") collectively hold all of the issued and outstanding shares of Iroko Pharmaceuticals Inc. CR Group L.P. may be deemed to beneficially own the Shares and the Warrants by virtue of its position as the investment manager for the Funds. This Form 3 is filed jointly by Iroko Pharmaceuticals Inc., Iroko Properties Inc., CR Group L.P. and each of the Funds. Pursuant to the terms of the Warrants, Iroko Properties Inc. has the right to acquire up to 2,436,459 additional shares of Common Stock, provided however that, for a period of eighteen (18) months following the date of the issuance of the Warrants, Iroko Properties Inc.'s right to exercise the Warrants is restricted so that it does not hold more than 49% of the issued and outstanding shares of Common Stock of the Issuer. The Warrants do not have an expiration date. /s/Nathan D. Hukill, authorized signatory for CR Group L.P. and each of the Funds 2019-02-11 /s/ Todd Holmes, authorized signatory for each of Iroko Pharmaceuticals Inc. and Iroko Properties Inc. 2019-02-11